Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14400
Articles
Company
Medical Device
Jenscare Scientific Submits CE Mark Application for JensClip TMVr System in EU
December 29, 2025
Company
Deals
TJ Biopharma Partners with Zhejiang Lab to Develop AI‑Driven Ultra‑Long‑Acting Growth Hormone
December 29, 2025
Company
Drug
Sino Biopharmaceutical’s TQH3906 Achieves 90% PASI 75 Response in Phase 2 Psoriasis Trial
December 29, 2025
Company
Deals
HBM Holdings and Lannacheng Biotech Forge Strategic Alliance for Next‑Generation RDCs in Precision Oncology
December 29, 2025
Company
Deals
Kleos Health and BioInno Bioscience Forge China Partnership for Exosome Drugs in Orthopedics
December 29, 2025
Company
Drug
AstraZeneca and Ionis’ Eplontersen Wins China Approval for ATTRv-PN as First Gene-Silencing Therapy
December 29, 2025
Company
Drug
AstraZeneca Secures NMPA Approval for Fasenra in EGPA, Demonstrating Superior Steroid-Sparing Effect
December 29, 2025
Company
Drug
Innovent Biologics Secures NMPA Approval for TABOSUN as First Neoadjuvant Dual‑IO Therapy for MSI‑H/dMMR Colon Cancer
December 29, 2025
Company
Medical Device
Wantai Biological Secures NMPA Approval for First Oral HIV Self-Test Kit in China
December 29, 2025
Company
Drug
Allist Pharmaceuticals Secures Breakthrough Therapy Designation for Furmonertinib in EGFR PACC‑Mutated NSCLC
December 29, 2025
Company
Medical Device
UniPath Bronchoscopic Robot Wins NMPA Approval, Expanding MedBot’s Surgical Portfolio
December 29, 2025
Company
Drug
Livzon’s Lecankitug Accepted by NMPA as First Domestic Dual IL‑17A/F Psoriasis Drug
December 29, 2025
1
2
…
197
198
199
200
201
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?